Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

173
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
173
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

151
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
151
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

230
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
230
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

87
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
87
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

151
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
151
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

149
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
149

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Burden of Cardiovascular Disease in China: Incidence Estimates From National Surveillance (2023).

Journal of the American College of Cardiology·2025
Same author

LDL-C-Related Cardiovascular Burden in China 2010 to 2030: Spatiotemporal Patterns and Scenario-Based Projections.

Journal of the American College of Cardiology·2025
Same author

Incidence and Burden of Cardiovascular Disease Attributable to Extreme Heat in China.

European journal of preventive cardiology·2025
Same author

Trends and sociodemographic patterns in hypertension prevalence and treatment in China.

Med (New York, N.Y.)·2025
Same author

Prevalence and Mortality of Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Population-Based Study.

JACC. Asia·2025
Same author

Relationship of Ambient Humidity with Cardiovascular Diseases: A Prospective Study of 24,510 Adults in a General Population.

Biomedical and environmental sciences : BES·2025

Related Experiment Video

Updated: Nov 21, 2025

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
08:17

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery

Published on: February 20, 2017

14.7K

Habitation Altitude and Left Ventricular Diastolic Function: A Population-Based Study.

Congyi Zheng1, Xin Wang1, Haosu Tang2,3

  • 1Division of Prevention and Community Health National Center for Cardiovascular Disease National Clinical Research Center of Cardiovascular Disease State Key Laboratory of Cardiovascular Disease Fuwai HospitalPeking Union Medical College and Chinese Academy of Medical Sciences Beijing China.

Journal of the American Heart Association
|January 18, 2021
PubMed
Summary

Higher altitude increases the risk of left ventricular diastolic dysfunction (LVDD), particularly in men living above 1500 meters. This study highlights altitude as a significant factor in cardiovascular health.

Keywords:
cross‐sectional studyhabitation altitudeleft ventricular diastolic functionpopulationrisk factor

More Related Videos

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
08:21

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice

Published on: June 15, 2020

4.6K
Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats
08:09

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats

Published on: December 13, 2019

22.2K

Related Experiment Videos

Last Updated: Nov 21, 2025

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
08:17

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery

Published on: February 20, 2017

14.7K
Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
08:21

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice

Published on: June 15, 2020

4.6K
Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats
08:09

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats

Published on: December 13, 2019

22.2K

Area of Science:

  • Cardiology
  • Environmental Health
  • Public Health

Background:

  • Conflicting evidence exists regarding the impact of altitude on cardiovascular disease.
  • Understanding altitude's role in cardiovascular health is crucial for public health initiatives.

Purpose of the Study:

  • To investigate the association between varying altitudes and the prevalence of left ventricular diastolic dysfunction (LVDD).
  • To identify specific risk factors and population subgroups affected by altitude-related LVDD.

Main Methods:

  • Cross-sectional study involving 34,215 residents aged ≥35 years in China.
  • LVDD diagnosed using 2009 American Society of Echocardiography guidelines.
  • Participants categorized into low (<1500 m), middle (1500-3500 m), and high (≥3500 m) altitude groups.

Main Results:

  • Prevalence of LVDD grades I, II, and III was 44.13%, 1.51%, and 0.79%, respectively.
  • Increased odds of LVDD observed in middle (OR 1.65) and high (OR 1.89) altitude groups compared to low altitude.
  • A nonlinear, upward-sloping relationship between altitude and LVDD risk was noted, with a significant interaction in men (P=0.0019).

Conclusions:

  • Higher altitudes (above 1500 m) are significantly associated with an increased risk of LVDD.
  • Men are particularly susceptible to the adverse cardiovascular effects of elevated altitudes.
  • Altitude should be considered a critical environmental determinant in cardiovascular disease risk assessment.